• Profile
Close

Low-dose dextromethorphan for the treatment of fibromyalgia pain: results from a longitudinal, single-blind, placebo-controlled pilot trial

Journal of Pain Research Jan 29, 2021

Mueller C, et al. - Via this single-blind, placebo-controlled trial, researchers sought to determine the effectiveness of dextromethorphan (DXM) in relieving fibromyalgia (FM)-associated symptoms. Forteen women with FM were provided a placebo for 5 weeks, followed by 20 mg DXM for 10 weeks, while providing daily symptom reports on a 0– 100 scale. The patients well tolerated DXM, and high treatment adherence was observed. Outcomes, however, indicated no strong clinical effect of DXM at the 20mg/day dosage.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay